BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6578450)

  • 1. A register of individuals with inborn errors of lipoprotein metabolism and their families.
    Robertson MC; Nye ER; Sutherland WH; Janus ED; Everest ER
    N Z Med J; 1983 Oct; 96(742):790-2. PubMed ID: 6578450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Screening and treatment of children and adolescents with hypercholesterolemias and dyslipidemias].
    Sobra J
    Cas Lek Cesk; 1998 Feb; 137(3):67-72. PubMed ID: 9511274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Congenital abnormalities of plasma lipoprotein metabolism].
    Yamamoto A; Yokoyama S
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):760-8. PubMed ID: 3270891
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic basis for hypertriglyceridaemia in familial combined hyperlipidaemia.
    Erkelens DW
    Eur Heart J; 1998 Jul; 19 Suppl H():H23-6. PubMed ID: 9717061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
    Zambon A; Brown BG; Deeb SS; Brunzell JD
    J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Familial combined hyperlipidemia: detection and characterisation of the hyperlipidemic profile among children and adolescents].
    Ribalta J; La Ville AE; Heras M; Plana N; Masana L
    Med Clin (Barc); 1997 Jun; 109(5):161-4. PubMed ID: 9289537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia].
    Ceska R; Sobra J; Kvasnicka J; Procházková R; Kvasilová M; Haas T
    Cas Lek Cesk; 1996 Jul; 135(13):413-6. PubMed ID: 8925538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inborn errors of lipid metabolism. Familial hyperlipoproteinaemia type 3. Detection of heterozygotes.
    Sobra J; Heyrovský A
    Rev Czech Med; 1972; 18(1):34-9. PubMed ID: 5022312
    [No Abstract]   [Full Text] [Related]  

  • 10. Are patients with familial hypercholesterolaemia well managed in lipid clinics? An audit of eleven clinics from the Department of Health Familial Hypercholesterolaemia Cascade Testing project.
    Hadfield SG; Horara S; Starr BJ; Yazdgerdi S; Bhatnagar D; Cramb R; Egan S; Everdell R; Ferns G; Jones A; Marenah CB; Marples J; Prinsloo P; Sneyd A; Stewart MF; Sandle L; Wang T; Watson MS; Humphries SE
    Ann Clin Biochem; 2008 Mar; 45(Pt 2):199-205. PubMed ID: 18325186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipid composition of high density lipoproteins in familial hyperlipoproteinemias].
    Tvorogova MG; Vasin PN; Rozhkova TA; Kukharchuk VV; Titov VN
    Vopr Med Khim; 1998; 44(5):452-8. PubMed ID: 9916260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and biochemical features of atherosclerosis main risk factors in children of probands with primary hyperlipidemia].
    Alidzhanova KhG; Tvorogova MG; Rozhkova TA; Balakhonova TV; Vorob'eva LP; Masenko VP; Kukharchuk VV
    Ter Arkh; 1998; 70(1):19-23. PubMed ID: 9532645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal lipid metabolism, familial hyperlipidaemia, lipid intervention and their benefits.
    Koner BC; Goswami K; Kavitha S; Moorthy RS
    J Indian Med Assoc; 2003 Feb; 101(2):89-92. PubMed ID: 12841490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid and lipoprotein metabolism in familial combined hyperlipidaemia during treatment of sporadic phaeochromocytoma: a case study.
    Winocour PH; Masud T; Clark F; Cooper BG; Laker MF; Alberti KG
    Postgrad Med J; 1992 May; 68(799):371-5. PubMed ID: 1630985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiopathology of plasma lipoprotein metabolism.
    Scanu AM
    Kidney Int Suppl; 1991 Apr; 31():S3-7. PubMed ID: 2046268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endothelial dysfunction in a family with familial combined hyperlipidemia].
    Karásek D; Vaverková H; Hutyra M; Halenka M; Novotnyý D; Budíková M; Slavík L
    Vnitr Lek; 2003 Aug; 49(8):623-9. PubMed ID: 14518086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A family-based strategy for diagnosing familial hypercholesterolemia].
    Leren TP; Manshaus T; Ose L
    Tidsskr Nor Laegeforen; 2004 May; 124(9):1228-9. PubMed ID: 15131703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic analysis of 1053 Danish individuals with clinical signs of familial hypercholesterolemia.
    Brusgaard K; Jordan P; Hansen H; Hansen AB; Hørder M
    Clin Genet; 2006 Mar; 69(3):277-83. PubMed ID: 16542394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common founder mutation in the LDL receptor gene causing familial hypercholesterolaemia in the Icelandic population.
    Gudnason V; Sigurdsson G; Nissen H; Humphries SE
    Hum Mutat; 1997; 10(1):36-44. PubMed ID: 9222758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results.
    Bourbon M; Rato Q;
    Rev Port Cardiol; 2006 Nov; 25(11):999-1013. PubMed ID: 17274457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.